This $385,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Wayne State University's research to develop therapeutic approaches targeting spiral ganglion-cochlear nucleus synaptopathy. The two-year award, running from September 1, 2023 to August 31, 2025, aims to transform health care for Service Members and the American public through innovative and impactful biomedical research. As a prominent public research university located in Detroit, Michigan, Wayne State University has a history of conducting studies and providing analyses for federal agencies, including a $5 million indefinite delivery, indefinite quantity contract with the National Highway Traffic Safety Administration and various grants from the National Institutes of Health and other agencies.
Generated 3/26/24, 4:51 PM